Overview Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of ONO-2506PO in patients with Parkinson's Disease Phase: Phase 2 Details Lead Sponsor: Ono Pharmaceutical Co. Ltd